Literature DB >> 14586172

Cdk7 functions as a cdk5 activating kinase in brain.

Jesusa Rosales1, Bingye Han, Ki-Young Lee.   

Abstract

Activity of Cdk5, which is essential for CNS development, depends on its association with p35 (or truncated p25) or p39, but the regulatory mechanisms whereby Cdk5 is activated have not yet been fully elucidated. Studies on PC12 cells showed that Cdk5/p25 activity is modulated by an unidentified kinase that phosphorylates Cdk5 at Ser159 and enhances its kinase activity (Sharma et al., 1999 PNAS USA 96,11156). In this study, we have partially purified a bovine brain enzyme that can phosphorylate the Cdk5(149-163) peptide but not the Cdk5(149-163)A159 peptide. The enzyme, which contains Cdk7, cyclin H, and Mat1, specifically phosphorylates Ser159 of Cdk5(149-163) and enhances Cdk5/p25 activity. The active Cdk7-containing enzyme also phosphorylates and activates wt Cdk5 but not mutated Cdk5(Ser159Ala). Likewise, Cdk7 or cyclin H immunoprecipitate from mouse brain specifically phosphorylates wt Cdk5 at Ser159 and enhances Cdk5/p25 activity. Conversely, blocked Cdk7 immunoprecipitate does not phosphorylate nor activate Cdk5. In addition, the Cdk7 substrate, CTD of RNAPII, causes a dose-dependent decline in Cdk5 activation by Cdk7. These findings indicate that Cdk7 functions as a Cdk5 activating kinase in brain. Indeed, elevated Cdk5 activity in the developing E18 mouse brain coincides with increased Cdk7 kinase activity. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14586172     DOI: 10.1159/000074543

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  7 in total

Review 1.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

2.  Protein kinase Czeta regulates Cdk5/p25 signaling during myogenesis.

Authors:  Aurélie de Thonel; Saima E Ferraris; Hanna-Mari Pallari; Susumu Y Imanishi; Vitaly Kochin; Tomohisa Hosokawa; Shin-ichi Hisanaga; Cecilia Sahlgren; John E Eriksson
Journal:  Mol Biol Cell       Date:  2010-03-03       Impact factor: 4.138

3.  Structural and dynamic determinants of ligand binding and regulation of cyclin-dependent kinase 5 by pathological activator p25 and inhibitory peptide CIP.

Authors:  A Cardone; S A Hassan; R W Albers; R D Sriram; H C Pant
Journal:  J Mol Biol       Date:  2010-06-25       Impact factor: 5.469

4.  Mat1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipocyte differentiation.

Authors:  Katja Helenius; Ying Yang; Jukka Alasaari; Tomi P Mäkelä
Journal:  Mol Cell Biol       Date:  2008-11-03       Impact factor: 4.272

5.  Tyrosine hydroxylase expression and Cdk5 kinase activity in ataxic cerebellum.

Authors:  K-John J Cheung; Jesusa L Rosales; Byung-Chul Lee; Young-Gil Jeong; Ki-Young Lee
Journal:  Mol Cell Biochem       Date:  2008-07-10       Impact factor: 3.396

Review 6.  Molecular pathology of neuro-AIDS (CNS-HIV).

Authors:  Leslie Crews; Christina Patrick; Cristian L Achim; Ian P Everall; Eliezer Masliah
Journal:  Int J Mol Sci       Date:  2009-03-11       Impact factor: 6.208

7.  ERK MAP kinase activation in spinal cord regulates phosphorylation of Cdk5 at serine 159 and contributes to peripheral inflammation induced pain/hypersensitivity.

Authors:  Xiaoqin Zhang; Honghai Zhang; Haijun Shao; Qingsheng Xue; Buwei Yu
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.